Gapping down
Other news:
- ARDX -5.6% (provides update on FDA appeal for XPHOZAH for the control of serum phosphorus in adult patients with Chronic Kidney Disease on Dialysis)
- YMAB -5.2% (The CHMP has Adopted a Negative Opinion for Omburtamab for the Treatment of CNS/LM Metastasis from Neuroblastoma in Europe)
- LHX -1.5% (to acquire AJRD)
- ONON -0.9% (files mixed securities shelf offering)
- RANI -0.8% (files for 6,009,542 share common stock offering by selling shareholders),
Analyst comments:
- LPX -1.5% (downgraded to Hold from Buy at TD Securities),
- T -0.9% (downgraded to Underperform from Market Perform at MoffettNathanson),